{"id":3086,"date":"2024-11-19T09:45:28","date_gmt":"2024-11-19T06:45:28","guid":{"rendered":"https:\/\/brand2d.tech\/gerties\/?p=3086"},"modified":"2024-11-19T09:50:09","modified_gmt":"2024-11-19T06:50:09","slug":"bo42451","status":"publish","type":"post","link":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/","title":{"rendered":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD)"},"content":{"rendered":"<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.<\/p>\n","protected":false},"author":33,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,20],"tags":[],"class_list":{"0":"post-3086","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-case-studies","7":"category-ongoing"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital\" \/>\n<meta property=\"og:description\" content=\"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\" \/>\n<meta property=\"og:site_name\" content=\"Gertrude&#039;s Children Hospital\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-19T06:45:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-19T06:50:09+00:00\" \/>\n<meta name=\"author\" content=\"Madeleine\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Madeleine\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\"},\"author\":{\"name\":\"Madeleine\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1\"},\"headline\":\"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD)\",\"datePublished\":\"2024-11-19T06:45:28+00:00\",\"dateModified\":\"2024-11-19T06:50:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\"},\"wordCount\":43,\"articleSection\":[\"Case Studies\",\"Ongoing\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\",\"url\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\",\"name\":\"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital\",\"isPartOf\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/#website\"},\"datePublished\":\"2024-11-19T06:45:28+00:00\",\"dateModified\":\"2024-11-19T06:50:09+00:00\",\"author\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1\"},\"breadcrumb\":{\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brand2d.tech\/gerties\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#website\",\"url\":\"https:\/\/brand2d.tech\/gerties\/\",\"name\":\"Gertrude&#039;s Children Hospital\",\"description\":\"Quality healthcare for children\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brand2d.tech\/gerties\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1\",\"name\":\"Madeleine\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9306827cacec5e943b19ba65e8eb5d33c7bf8270c19720a666a546e5094ef407?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9306827cacec5e943b19ba65e8eb5d33c7bf8270c19720a666a546e5094ef407?s=96&d=mm&r=g\",\"caption\":\"Madeleine\"},\"url\":\"https:\/\/brand2d.tech\/gerties\/author\/madeleine\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/","og_locale":"en_US","og_type":"article","og_title":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital","og_description":"Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros.","og_url":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/","og_site_name":"Gertrude&#039;s Children Hospital","article_published_time":"2024-11-19T06:45:28+00:00","article_modified_time":"2024-11-19T06:50:09+00:00","author":"Madeleine","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Madeleine","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#article","isPartOf":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/"},"author":{"name":"Madeleine","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1"},"headline":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD)","datePublished":"2024-11-19T06:45:28+00:00","dateModified":"2024-11-19T06:50:09+00:00","mainEntityOfPage":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/"},"wordCount":43,"articleSection":["Case Studies","Ongoing"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/","url":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/","name":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD) - Gertrude&#039;s Children Hospital","isPartOf":{"@id":"https:\/\/brand2d.tech\/gerties\/#website"},"datePublished":"2024-11-19T06:45:28+00:00","dateModified":"2024-11-19T06:50:09+00:00","author":{"@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1"},"breadcrumb":{"@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brand2d.tech\/gerties\/2024\/11\/19\/bo42451\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brand2d.tech\/gerties\/"},{"@type":"ListItem","position":2,"name":"2022 BO42451 \u2013 A Randomized Double-Blind Phase IIa Study Evaluating The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Crovalimab As Adjunct Treatment In Prevention Of Vaso-Occlusive Episodes (Voe) In Sickle Cell Disease (SCD)"}]},{"@type":"WebSite","@id":"https:\/\/brand2d.tech\/gerties\/#website","url":"https:\/\/brand2d.tech\/gerties\/","name":"Gertrude&#039;s Children Hospital","description":"Quality healthcare for children","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brand2d.tech\/gerties\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/6f8f73a9fb130f858c67e0a937fc47a1","name":"Madeleine","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/brand2d.tech\/gerties\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9306827cacec5e943b19ba65e8eb5d33c7bf8270c19720a666a546e5094ef407?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9306827cacec5e943b19ba65e8eb5d33c7bf8270c19720a666a546e5094ef407?s=96&d=mm&r=g","caption":"Madeleine"},"url":"https:\/\/brand2d.tech\/gerties\/author\/madeleine\/"}]}},"_links":{"self":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts\/3086","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/comments?post=3086"}],"version-history":[{"count":0,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/posts\/3086\/revisions"}],"wp:attachment":[{"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/media?parent=3086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/categories?post=3086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brand2d.tech\/gerties\/wp-json\/wp\/v2\/tags?post=3086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}